All blog posts
Total 51 results for
Showing 12 out of 51 results
12 3월 2026
Snapshot: Key European pharma regulatory, IP and competition developments from 2025 for the pharmaceutical sector
18 8월 2025
Pharma remains an enforcement focus in China – SAMR orders unwinding of a completed pharma deal
18 3월 2025
Navigating competition law and FDI regulation in the pharmaceuticals sector - 2025 Outlook
30 1월 2025
The UPC at 18 months
15 8월 2024
H1 2024 – a steady start for biopharma M&A
16 7월 2024
UPC revokes Amgen's patent in the first case filed at the UPC
02 7월 2024
Recent additions to Life Sciences Notes
28 6월 2024
Overview of EU regulatory and competition law in the Pharma sector
12 4월 2024
HSF Patent team named best in Europe by Managing IP
13 3월 2024
Recent additions to Life Sciences Notes
19 2월 2024
Five Years of Activity in a Priority Sector: The European Commission's Report on Competition Enforcement in the Pharmaceutical Sector (2018-2022)
12 1월 2024
The UPC – 2023's achievements and predictions for 2024
Showing 12 out of 51 results
View moreKey contacts
Laura Orlando
Managing Partner, Milan Office, Milan
Alan Montgomery
Partner, Head of Pharmaceuticals Sector, Chair of India Group, London
Chris Parker KC
Partner, Head of Pharmaceuticals Sector, London